BioStrand

About:

BioStrand is advancing technology for analyzing genetic data, which will drive innovation in the fields of precision medicine.

Website: https://www.biostrand.be

Twitter/X: BioStrandBV

Top Investors: Agentschap Innoveren & Ondernemen, K & E

Description:

BioStrand offers a revolutionary methodology for identifying similarities and variations in genetic data and detecting structural anchor points that will drive innovation in precision medicine, drug development and agriculture. The BioStrand methodology enables unprecedented accuracy in detecting similarities and variations in DNA, RNA and proteins. By detecting HYFTSTM, structural 3D information is automatically integrated into the analyses, revolutionising pattern and profile detection that are critical in unraveling diseases and biological processes.

Total Funding Amount:

2.7M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Diepenbeek, Limburg, Belgium

Founded Date:

2019-01-01

Contact Email:

info(AT)biostrand.be

Founders:

Dirk Van Hyfte, Ingrid Brands

Number of Employees:

11-50

Last Funding Date:

2022-05-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai